Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models

Neuroscience Letters

Volumn 487, Issue 1, 2011, Pages 94-98

  Li, Y Y ^a   Cui, J G ^a   Hill, J M ^a   Bhattacharjee, S ^a   Zhao, Y ^b   Lukiw, W J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

5xFAD; Alzheimer's disease; CAY10512; Curcumin; MiRNA 146a; Neurodegeneration; NF B; PDTC; Tg2576; Transgenic models of Alzheimer's disease

Indexed keywords

CURCUMIN; I KAPPA B; INTERLEUKIN 1BETA; MICRORNA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NEOCORTEX; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RETINA CELL; TRANSGENIC MOUSE; UPREGULATION;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; MUTATION; NEOCORTEX; PRESENILIN-1; TAU PROTEINS; TRANSFECTION; UP-REGULATION;

EID: 78650221283     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.09.079     Document Type: Article

References (30)

1. Ashe K.H., Zahs K.R. Probing the biology of Alzheimer's disease in mice. Neuron 2010, 66:631-645.
2. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 2001, 276:21562-21570.
3. Dong H., Martin M.V., Chambers S., Csernansky J.G. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J. Comp. Neurol. 2007, 500:311-321.
4. Gouras G.K., Tampellini D., Takahashi R.H., Capetillo-Zarate E. Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol. 2010, 119:523-541.
5. Hill J.M., Zhao Y., Clement C., Neumann D.M., Lukiw W.J. HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. Neuroreport 2009, 20:1500-1505.
6. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 1998, 4:97-100.
7. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 1996, 274:99-102.
8. Jellinger K.A. Clinicopathological analysis of dementia disorders in the elderly. J. Alzheimers Dis. 2006, 9:61-70.
9. King D.L., Arendash G.W. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res. 2002, 926:58-68.
10. Kumar-Singh S., Pirici D., McGowan E., Serneels S., Ceuterick C., Hardy J., Duff K., Dickson D., Van Broeckhoven C.C. Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am. J. Pathol. 2005, 167:527-543.
11. Li L., Chen X.P., Li Y.J. MiRNA-146a and human disease. Scand. J. Immunol. 2010, 71:227-231.
12. Lukiw W.J. Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 2004, 29:1287-1297.
13. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18:297-300.
14. Lukiw W.J, Pogue A.I. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem. 2007, 101:1265-1269.
15. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., Serhan C.N., Bazan N.G. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 2005, 115:2774-2783.
16. Lukiw W.J., Zhao Y., Cui J.G. An NF-k{cyrillic}B-sensitive miRNA-146a-mediated inflammatory circuit in AD and in stressed human brain cells. J. Biol. Chem. 2008, 283:31315-31322.
17. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006, 26:10129-10140.
18. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 2003, 39:409-421.
19. Philipson O., Lord A., Gumucio A., O'Callaghan P., Lannfelt L., Nilsson L.N. Animal models of amyloid-beta-related pathologies in Alzheimer's disease. FEBS J. 2010, 277:1389-1409.
20. Pogue A.I., Li Y.Y., Cui J.G., Zhao Y., Kruck T.P., Percy M.E., Tarr M.A., Lukiw W.J. Characterization of an NF-kB-regulated miRNA-146a in metal-sulfate-stressed human brain cells. J. Inorg. Biochem. 2009, 11:156-164.
21. Pogue A.I., Cui J.G., Li Y.Y., Zhao Y., Culicchia F., Lukiw W.J. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci. Lett. 2010, 476:18-22.
22. Provost P. MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases. Brain Res. 2010, 1338:58-66.
23. Saba R., Goodman C.D., Huzarewich R.L., Robertson C., Booth S.A. A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3:e3652.
24. Sethi P., Lukiw W.J. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci. Lett. 2009, 459:100-104.
25. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of miRNA-146a, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
26. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., Gouras G.K. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 2002, 161:1869-1879.
27. Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Hsiao Ashe K., Hasegawa M., Mann D.M., Hyman B.T., Iwatsubo T. Age-related amyloid beta deposition in transgenic mice over-expressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am. J. Pathol. 2000, 157:331-339.
28. Townsend M., Qu Y., Gray A., Wu Z., Seto T., Hutton M., Shearman M.S., Middleton R.E. Oral treatment with a gamma-secretase inhibitor in a mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 2010, 333:110-119.
29. van Spronsen M., Hoogenraad C.C. Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep. 2010, 10:207-214.
30. Zhang X.M., Cai Y., Xiong K., Cai H., Luo X.G., Feng J.C., Clough R.W., Struble R.G., Patrylo P.R., Yan X.X. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur. J. Neurosci. 2009, 30:2271-2283.